What is Nuvation Bio's current ratio?

Nuvation Bio (NUVB) reported current ratio of 7.4× in Q1 2026.

How has Nuvation Bio's current ratio changed year-over-year?

Nuvation Bio's current ratio decreased by 17.5% year-over-year, from 9× to 7.4×.

What is the long-term trend for Nuvation Bio's current ratio?

Over 5 years (2020 to 2025), Nuvation Bio's current ratio has grown at a -27.1% compound annual growth rate (CAGR), from 33.7× to 7×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Nuvation Bio NUVB Current ratio

Current ratio at other companies

Bristol-Myers SquibbBMY

1.4×+0.1×

PfizerPFE

1.2×0.0×

Nuvalent, Inc.NUVL

16.1×+1.7×

ImmunomeIMNM

21.7×+11.2×

ArriVent BioPharma, Inc.AVBP

14×-0.4×

Arcus BiosciencesRCUS

4×-1.3×

Other financials

Income statement

See full

Revenue$83.2M+2,599%

Gross profit$9.8M+1,340%

Operating income$3.9M+107%

Net income$5.4M+110%

EPS (diluted)$0.01+106%

Balance sheet

See full

Cash & equivalents$125.4M+161%

Total debt$57.2M+401%

Total equity$319.6M-23.8%

Total assets$610.2M+23.9%

Cash flow

See full

Operating cash flow$5.1M+112%

CapEx$48.0K-33.3%

Free cash flow$5.0M+112%

Valuation

See full

Market cap$2.1B+150%

Enterprise value$2.03B+154%

P/S14.7×-62.0×

Profitability

See full

Gross margin54.3%+39.5pp

Operating margin-105%-52.0pp

Net margin-102.1%-50.6pp

FCF margin-93.5%-45.2pp

Returns & leverage

See full

Return on equity-39.5%-15.8pp

Debt / equity0.2×+0.2×

Where this comes from

Calculated from Nuvation Bio’s reported figures.

total current assets/total current liabilities=7.4×

Based on the most recent quarter.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nuvation Bio's current ratio?: Nuvation Bio (NUVB) reported current ratio of 7.4× in Q1 2026.
How has Nuvation Bio's current ratio changed year-over-year?: Nuvation Bio's current ratio decreased by 17.5% year-over-year, from 9× to 7.4×.
What is the long-term trend for Nuvation Bio's current ratio?: Over 5 years (2020 to 2025), Nuvation Bio's current ratio has grown at a -27.1% compound annual growth rate (CAGR), from 33.7× to 7×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.